SCARNA21B

Across TCGA pan-cancer cohorts, SCARNA21B RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SCARNA21B’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where SCARNA21B RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SCARNA21B is over-expressed in tumor.

BRCA and KIRC are the cancer types where SCARNA21B tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SCARNA21B RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.111	.036	4	view →
KIRC	Male	All	+0.044	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

SCARNA21B–BRCA

Open the BRCA breakdown →